NanoViricides (NNVC)
(Delayed Data from AMEX)
$1.10 USD
-0.01 (-0.90%)
Updated Apr 26, 2024 03:51 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for NanoViricides, Inc falls in the month of June .
All items in Millions except EPS data.
6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | 6/30/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | 0 | 0 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 9 | 8 | 9 | 8 | 9 |
Income After Depreciation & Amortization | -9 | -8 | -9 | -8 | -9 |
Non-Operating Income | 0 | 0 | 0 | -5 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -9 | -8 | -9 | -13 | -8 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -9 | -8 | -9 | -13 | -8 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -9 | -8 | -9 | -13 | -8 |
Depreciation Footnote | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | 6/30/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -8 | -7 | -8 | -7 | -8 |
Depreciation & Amortization (Cash Flow) | 1 | 1 | 1 | 1 | 1 |
Income After Depreciation & Amortization | -9 | -8 | -9 | -8 | -9 |
Earnings Per Share Data | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | 6/30/19 |
---|---|---|---|---|---|
Average Shares | 11.63 | 11.54 | 10.90 | 5.62 | 3.59 |
Diluted EPS Before Non-Recurring Items | -0.74 | -0.70 | -0.81 | -2.39 | -2.40 |
Diluted Net EPS (GAAP) | -0.74 | -0.70 | -0.81 | -2.39 | -2.40 |
Fiscal Year end for NanoViricides, Inc falls in the month of June .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | NA | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 2.18 | 2.03 | 3.67 | 1.81 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -2.18 | -2.03 | -3.67 | -1.81 |
Non-Operating Income | NA | 0.08 | 0.10 | 0.11 | 0.11 |
Interest Expense | NA | 0.01 | 0.04 | 0.00 | 0.00 |
Pretax Income | NA | -2.11 | -1.97 | -3.57 | -1.70 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -2.11 | -1.97 | -3.57 | -1.70 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -2.11 | -1.97 | -3.57 | -1.70 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 11.75 | 11.72 | 11.52 | 11.64 |
Diluted EPS Before Non-Recurring Items | NA | -0.18 | -0.17 | -0.31 | -0.15 |
Diluted Net EPS (GAAP) | NA | -0.18 | -0.17 | -0.30 | -0.15 |